Fed Ghali, MD

Articles by Fed Ghali, MD

Challenges in plasmacytoid urothelial carcinoma underscore need for novel treatment options

January 17th 2025

“If patients are not experiencing a clear clinical benefit for chemotherapy prior to surgery, we need to be really thoughtful about how we use it,” says Fed Ghali, MD.

Fed Ghali, MD, on clinical outcomes in plasmacytoid urothelial carcinoma

ByFed Ghali, MD

January 13th 2025

“It's hard for us, based on our evidence here, to say that neoadjuvant chemotherapy is causal in any way or is resulting in prolonged survival,” says Fed Ghali, MD.

Fed Ghali, MD

Articles by Fed Ghali, MD

Challenges in plasmacytoid urothelial carcinoma underscore need for novel treatment options

Fed Ghali, MD, on clinical outcomes in plasmacytoid urothelial carcinoma

Latest Updated Articles

Trending on Urology Times

Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy

PROSTOX ultra launches on US market following new data presented at ASTRO 2025

Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC

Published data show benefit of niraparib with AAP in HRR-deficient mCSPC

Andrea B. Apolo, MD, discusses survival gains with EV/pembrolizumab in bladder cancer